Research programme: triplex-forming oligonucleotides - University of Utah
Alternative Names: TFO1; TFO3; Triplex-forming oligonucleotides research programme - University of UtahLatest Information Update: 25 Aug 2006
Price :
$50 *
At a glance
- Originator University of Utah
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections
Most Recent Events
- 25 Aug 2006 No development reported - Preclinical for Herpes simplex virus infections in USA (unspecified route)
- 06 May 2003 Preclinical trials in Herpes simplex virus infections in USA (unspecified route)
- 06 May 2003 Data presented at the 16th International Conference on Antiviral Research (ICAR-2003) have been added to the Viral infections pharmacodynamics section